Globe Life (NYSE:GL) Price Target Raised to $137.00 at Keefe, Bruyette & Woods

Globe Life (NYSE:GL - Get Free Report) had its target price boosted by stock analysts at Keefe, Bruyette & Woods from $135.00 to $137.00 in a research note issued on Friday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Keefe, Bruyette & Woods' target price suggests a potential upside of 21.77% from the company's current price.

Several other equities research analysts have also recently issued reports on the stock. Jefferies Financial Group raised their target price on shares of Globe Life from $107.00 to $114.00 and gave the stock a "hold" rating in a report on Tuesday, December 10th. Wells Fargo & Company raised their target price on shares of Globe Life from $108.00 to $117.00 and gave the stock an "overweight" rating in a report on Thursday, October 10th. Raymond James raised their target price on shares of Globe Life from $160.00 to $188.00 and gave the stock a "strong-buy" rating in a report on Tuesday, October 15th. Evercore ISI upgraded shares of Globe Life from an "in-line" rating to an "outperform" rating and increased their price target for the stock from $132.00 to $143.00 in a research report on Wednesday. Finally, TD Cowen started coverage on shares of Globe Life in a research report on Wednesday, October 9th. They issued a "buy" rating and a $150.00 price target on the stock. Four research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Globe Life currently has a consensus rating of "Moderate Buy" and a consensus target price of $134.00.

Globe Life Stock Down 1.4 %

GL traded down $1.61 during midday trading on Friday, reaching $112.51. The company's stock had a trading volume of 772,560 shares, compared to its average volume of 695,860. The firm has a market capitalization of $9.44 billion, a price-to-earnings ratio of 9.52 and a beta of 0.80. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. Globe Life has a 1 year low of $38.95 and a 1 year high of $132.00. The stock's 50-day moving average is $108.89 and its 200-day moving average is $101.76.

Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $3.49 earnings per share for the quarter, topping analysts' consensus estimates of $3.06 by $0.43. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.46 billion. Globe Life had a net margin of 19.04% and a return on equity of 22.91%. The business's revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.71 earnings per share. As a group, research analysts expect that Globe Life will post 12.31 EPS for the current year.

Insider Buying and Selling

In other Globe Life news, Director Mark A. Blinn sold 3,000 shares of the business's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the sale, the director now directly owns 5,122 shares of the company's stock, valued at $579,964.06. The trade was a 36.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 13,448 shares of the business's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the completion of the sale, the chief executive officer now directly owns 18,948 shares of the company's stock, valued at approximately $2,132,786.88. This trade represents a 41.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,788 shares of company stock valued at $4,429,779. Company insiders own 1.51% of the company's stock.

Institutional Investors Weigh In On Globe Life

Hedge funds have recently modified their holdings of the business. Versant Capital Management Inc lifted its position in Globe Life by 388.0% during the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company's stock valued at $27,000 after acquiring an additional 194 shares during the last quarter. Riverview Trust Co purchased a new stake in Globe Life during the third quarter valued at approximately $32,000. Benjamin F. Edwards & Company Inc. lifted its position in Globe Life by 88.4% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 599 shares of the company's stock valued at $50,000 after acquiring an additional 281 shares during the last quarter. True Wealth Design LLC purchased a new stake in Globe Life during the third quarter valued at approximately $59,000. Finally, Quarry LP lifted its position in Globe Life by 47.5% during the second quarter. Quarry LP now owns 838 shares of the company's stock valued at $69,000 after acquiring an additional 270 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.